US Bancorp
- SEC CIK
- 0000036104
- Latest filing
- Aug 12, 2026
TRDA holding history
Entrada Therapeutics, Inc. in every 13F filed by US Bancorp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
TRDA overviewAll 13F holders of TRDAFull Q2 2026 holdings
- Shares (Q2 2026)
- 0
- Sold out in Q2 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 5
- Since Q3 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 0 | $0 | 0.0% | −70−100.0% | Sold out | Holders |
| Q1 2026 | 70 | $883 | <0.1% | +70 | New | Holders |
| Q3 2025 | 0 | $0 | 0.0% | −2,868−100.0% | Sold out | Holders |
| Q2 2025 | 2,868 | $19.3K | <0.1% | −283−9.0% | Reduced | Holders |
| Q1 2025 | 3,151 | $28.5K | <0.1% | +493+18.5% | Added | Holders |
| Q4 2024 | 2,658 | $46.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 2,658 | $42.5K | <0.1% | +2,658 | New | Holders |